Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.

HOPE Therapeutics Starts ONE-D Depression Treatment

HOPE Therapeutics, an interventional psychiatry network owned by NRx Pharmaceuticals, Inc. announced initiation of patient care with for treatment-resistant depression with the Ampa one day (ONE-D) protocol. HOPE is the first to deploy the Ampa technology in Florida and one of the first deployments nationwide. The Ampa device differs from other Transcranial Magnetic Stimulation (TMS) treatments in that the peer-reviewed literature has reported a high rate of success (87% response and 72% remission) in nonrandomized trials when a single day of TMS treatment is combined with physician-prescribed D-cycloserine and lisdexamfetamine (note that neither of the drugs reported in the published results is FDA-approved for the stated indication). D-cycloserine was previously reported to substantially enhance the effectiveness of TMS in reducing depression and suicidality by more than two-fold in a placebo-controlled trial using a traditional TMS protocol.   Additional supportive findings documenting the effect of D-cycloserine in enhancing the effect of TMS were recently published by a team of researchers led by Prof. Joshua Brown at Harvard’s McLean hospital. Dr. Brown additionally serves as the President of the Clinical TMS Society.

Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities

Revvity, Inc. announced it has entered into a definitive agreement to acquire ACD/Labs, a global provider of scientific software solutions that support analytical characterization and molecular design across pharmaceutical and material sciences end markets. This acquisition expands the breadth and depth of Revvity Signals’ solutions for bridging the gap between analytical data and actionable insights, further strengthening its ability to accelerate scientific innovation. The transaction is expected to close late in Q4 2025.

Talkspace Launches Chapters to Support Women’s Mental Health

Talkspace, a leading online behavioral health company, has introduced Chapters, a new program designed to meet the mental health needs of women at every stage of life. Chapters provides personalized care pathways tailored to each individual, addressing key life transitions from adolescence and young adulthood to family planning, pregnancy, postpartum, midlife, menopause, and caregiving in later years. The program aims to close longstanding gaps in mental health care by offering targeted support for challenges unique to women’s experiences.

Healthcare Therapy Services, Inc. (HTS) Notifies Patients of Data Security Incident

Healthcare Therapy Services, Inc., known as HTS, announced that it discovered a potential data security incident affecting patient information. The company promptly notified individuals who may have been involved and provided guidance to help protect their personal data.

Virtuoso Surgical Adds Healthcare Innovator Rob Waggener to Board of Directors

Virtuoso Surgical, Inc., a Nashville-based company developing a groundbreaking new class of robotic tools for endoscopic surgery, announced that nationally recognized healthcare entrepreneur and investor Robert Waggener has joined its Board of Directors. For decades, Waggener has earned a reputation in the healthcare industry as an innovator, a connector, and a leader of change and through change.

To share your insights, please write to us at tony@intentamplify.com